ALX Oncology Holdings Inc.
ALXO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$134,850 | -$160,805 | -$123,482 | -$83,463 |
| Dep. & Amort. | $872 | $836 | $342 | $51 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $27,093 | $26,273 | $23,839 | $13,914 |
| Change in WC | -$12,430 | $8,297 | $9,850 | -$4,027 |
| Other Non-Cash | -$2,597 | -$4,965 | $228 | $5,424 |
| Operating Cash Flow | -$121,912 | -$130,364 | -$89,223 | -$68,101 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$447 | -$1,274 | -$1,427 | -$4,923 |
| Net Acquisitions | $0 | $0 | $234 | $0 |
| Inv. Purchases | -$107,406 | -$246,629 | -$376,789 | $0 |
| Inv. Sales/Matur. | $194,109 | $292,560 | $142,800 | $0 |
| Other Inv. Act. | $0 | $0 | -$234 | $0 |
| Investing Cash Flow | $86,256 | $44,657 | -$235,416 | -$4,923 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$827 | -$388 | $9,612 | -$281 |
| Stock Issued | $31,644 | $58,887 | $903 | $2,753 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $792 | -$655 | $0 |
| Financing Cash Flow | $30,817 | $59,291 | $9,860 | $2,472 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$4,839 | -$26,416 | -$314,779 | -$70,552 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,472 | $48,888 | $363,667 | $434,219 |
| End Cash | $17,633 | $22,472 | $48,888 | $363,667 |
| Free Cash Flow | -$122,359 | -$131,638 | -$90,650 | -$73,024 |